Becton, Dickinson and Company BDX EBITDA

EBITDA at other companies

AbbottABT

$2.75B-2.7%

Baxter InternationalBAX

$303M-0.7%

TFX

TeleflexTFX

$73.93M-35.4%

Thermo Fisher ScientificTMO

$2.6B+7.4%

West Pharmaceutical ServicesWST

$225.3M+15.5%

Bio-Rad LaboratoriesBIO

——

FAQ

What is Becton, Dickinson and Company's EBITDA?

Becton, Dickinson and Company (BDX) reported EBITDA of $656M in Q1 2026.

How has Becton, Dickinson and Company's EBITDA changed year-over-year?

Becton, Dickinson and Company's EBITDA decreased by 30.9% year-over-year, from $950M to $656M.

What is the long-term trend for Becton, Dickinson and Company's EBITDA?

Over 4 years (2021 to 2025), Becton, Dickinson and Company's EBITDA has grown at a 0.7% compound annual growth rate (CAGR), from $4.78B to $4.92B.

What does EBITDA mean?

Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.